NeuroVive Pharmaceutical AB ROIC
Was ist das ROIC von NeuroVive Pharmaceutical AB?
ROIC von NeuroVive Pharmaceutical AB ist -152.24%
Was ist die Definition von ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC von Unternehmen in Miscellaneous Sektor auf LSE im Vergleich zu NeuroVive Pharmaceutical AB
Was macht NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Unternehmen mit roic ähnlich NeuroVive Pharmaceutical AB
- Predictmedix hat ROIC von -154.59%
- Helius Medical Technologies hat ROIC von -154.03%
- Titan Medical hat ROIC von -153.87%
- Cardinal Resources hat ROIC von -153.72%
- Ecc Ventures 3 Corp hat ROIC von -153.21%
- Thin Film Electronics ASA hat ROIC von -152.63%
- NeuroVive Pharmaceutical AB hat ROIC von -152.24%
- URA Plc hat ROIC von -152.11%
- Josemaria Resources hat ROIC von -151.90%
- Canadian Cannabis hat ROIC von -151.48%
- Ximen Mining hat ROIC von -150.81%
- Euro Sun Mining hat ROIC von -150.66%
- Eskay Mining hat ROIC von -150.63%